2008•Unpublished venueRequires access

Study on rhG-CSF combined with improved CVP mobilization regimen in autologous peripheral blood stem cell transplantation in 41 patients with hematological malignancies and solid neoplasms

Hua He

Open publisher page 0 citations

Abstract

Objective:To evaluate the mobilization and hematopoietic reconstitution effects of improved CVP mobilization regimen plus rhG-CSF in 41 autologous peripheral blood stem cells transplantation(APBSCT)patients with hematological malignancies and solid neoplasms.Methods:Forty-one patients aged 39.6 years(range,18~67 years)(32 with hematological malignancies and 9 with solid neoplasms)were included from March 2001 to March 2006.The mobilization regimen was improved CVP regimen plus rhG-CSF.Mononuclear cells(MNC)harvest was performed when WBC recovered more than 4.0×109/L,and the MNC and CD34+ cells were counted.MNC was reinfused 48~72 hours after preconditioning of high dose chemotherapy.Results:WBC and PLT decreased to 1.0×109/L(0.1×109/L~0.8×109/L)and 40×109/L(4×109/L~36×109/L)respectively after mobilizing chemotherapy in all patients.Thirty four patients completed collection with a single apheresis,and 7 patients(5 patients with double APBSCT)underwent twice.The number of MNC and CD34+ cells obtained were 0.9×108/kg~8.3×108/kg(2.8±2.0×108/kg)and 1.1×106/kg ~9.4×106/kg(3.2±2.6×106/kg).No severe toxic reactions were observed.After conditioning,WBC recovered to 1.0×109/L at a median time of +11.3d(range +8~+16d),and PLT recovered to 50×109/L at a median time of +16.8d(range +13~+22d)except 3 patients.With a follow-up of 5 to 65 months after transplant,19 patients achieved complete remission(46.3%),13 patients partial remission(31.7%)and 9 patients no effects(22.0%).Conclusion:Improved CVP combined with rhG-CSF was a safe and effective regimen for the mobilization,which can be used in APBSCT with satisfying outcomes.

About this research paper

What this paper is about

Objective:To evaluate the mobilization and hematopoietic reconstitution effects of improved CVP mobilization regimen plus rhG-CSF in 41 autologous peripheral blood stem cells transplantation(APBSCT)patients with hematological malignancies and solid neoplasms.Methods:Forty-one patients aged 39.6 years(range,18~67 years)(32 with hematological malignancies and 9 with solid neoplasms)were included from March 2001 to March 2006.The mobilization regimen was improved CVP regimen plus rhG-CSF.Mononuclear cells(MNC)harvest was performed when WBC recovered more than 4.0×109/L,and the MNC and CD34+ cells were counted.MNC was reinfused 48~72 hours after preconditioning of high dose chemotherapy.Results:WBC and PLT decreased to 1.0×109/L(0.1×109/L~0.8×109/L)and 40×109/L(4×109/L~36×109/L)respectively after mobilizing chemotherapy in all patients.Thirty four patients completed collection with a single apheresis,and 7 patients(5 patients with double APBSCT)underwent twice.The number of MNC and CD34+ cells obtained were 0.9×108/kg~8.3×108/kg(2.8±2.0×108/kg)and 1.1×106/kg ~9.4×106/kg(3.2±2.6×106/kg).No severe toxic reactions were observed.After conditioning,WBC recovered to 1.0×109/L at a median time of +11.3d(range +8~+16d),and PLT recovered to 50×109/L at a median time of +16.8d(range +13~+22d)except 3 patients.With a follow-up of 5 to 65 months after transplant,19 patients achieved complete remission(46.3%),13 patients partial remission(31.7%)and 9 patients no effects(22.0%).Conclusion:Improved CVP combined with rhG-CSF was a safe and effective regimen for the mobilization,which can be used in APBSCT with satisfying outcomes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the mobilization and hematopoietic reconstitution effects of improved CVP mobilization regimen plus rhG-CSF in 41 autologous peripheral blood stem cells transplantation(APBSCT)patients with hematological malignancies and solid neoplasms.Methods:Forty-one patients aged 39.6 years(range,18~67 years)(32 with hematological malignancies and 9 with solid neoplasms)were included from March 2001 to March 2006.The mobilization regimen was improved CVP regimen plus rhG-CSF.Mononuclear cells(MNC)harvest was performed when WBC recovered more than 4.0×109/L,and the MNC and CD34+ cells were counted.MNC was reinfused 48~72 hours after preconditioning of high dose chemotherapy.Results:WBC and PLT decreased to 1.0×109/L(0.1×109/L~0.8×109/L)and 40×109/L(4×109/L~36×109/L)respectively after mobilizing chemotherapy in all patients.Thirty four patients completed collection with a single apheresis,and 7 patients(5 patients with double APBSCT)underwent twice.The number of MNC and CD34+ cells obtained were 0.9×108/kg~8.3×108/kg(2.8±2.0×108/kg)and 1.1×106/kg ~9.4×106/kg(3.2±2.6×106/kg).No severe toxic reactions were observed.After conditioning,WBC recovered to 1.0×109/L at a median time of +11.3d(range +8~+16d),and PLT recovered to 50×109/L at a median time of +16.8d(range +13~+22d)except 3 patients.With a follow-up of 5 to 65 months after transplant,19 patients achieved complete remission(46.3%),13 patients partial remission(31.7%)and 9 patients no effects(22.0%).Conclusion:Improved CVP combined with rhG-CSF was a safe and effective regimen for the mobilization,which can be used in APBSCT with satisfying outcomes.

Key concepts: Medicine, Apheresis, Regimen, Mobilization, Transplantation, Chemotherapy, Gastroenterology, Granulocyte colony-stimulating factor

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on rhG-CSF combined with improved CVP mobilization regimen in autologous peripheral blood stem cell transplantation in 41 patients with hematological malignancies and solid neoplasms — Research Paper | ScholarLens